| James D. Griffin | |
|---|---|
| Born | James Douglas Griffin Syracuse, New York |
| Alma mater | |
| Scientific career | |
| Institutions | |
James D. Griffin is an American physician-scientist. He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital. He is considered an expert in medical oncology and is widely recognized for his research in the clinical and biologic aspects of hemotologic malignancies.
Griffin completed a Bachelor of Arts at Brown University in 1970. He attended Harvard Medical School, earning his M.D. in 1974. Griffin completed his residency at Johns Hopkins Hospital, a hematology fellowship at Massachusetts General Hospital, and a medical oncology fellowship at Dana–Farber Cancer Institute.
He is on the scientific advisory boards of Phio Pharmaceuticals, the Georgetown Lombardi Comprehensive Cancer Center, and the Johns Hopkins Cancer Center.
Griffin was born in Syracuse, New York. He is a seventh-generation Irish American.
References
- "James D. Griffin, MD - Dana-Farber Cancer Institute | Boston, MA". www.dana-farber.org. Retrieved 2022-02-05.
- "James D. Griffin, MD - DF/HCC". www.dfhcc.harvard.edu. Retrieved 2022-02-05.
- Corporation, RXi Pharmaceuticals. "RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory Board". www.prnewswire.com. Retrieved 2022-02-05.
- walid (2021-06-28). "Phio Pharmaceuticals | About Us". phiopharma.com. Retrieved 2022-02-05.
- "James Griffin". Irish America. Retrieved 2022-02-05.
External links
- James D. Griffin publications indexed by Google Scholar
   | This biographical article related to medicine in the United States is a stub. You can help Misplaced Pages by expanding it. |